Kaiser Foundation Hospitals

Kaiser Foundation Hospitals was paid $36.92M by Medicaid between Jan 2018 and Dec 2024, across 271 billing codes. Its largest line is 99283, emergency room visit (moderate) — 33% of everything it billed.

33Billing provider infoKAISER FOUNDATION HOSPITALS
WOODLAND HILLS, CA 91367

33aNPI1295880912assigned 01/24/2007

33bProvider typeGeneral Acute Care Hospital

28Total paid$36.92M

24GClaims878,152

24DCodes billed271

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#79 of 410

Median peer was paid$6.90M

This provider vs. median5.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	85,183	$230K
2019	104,687	$4.18M
2020	93,347	$6.15M
2021	113,571	$5.19M
2022	131,189	$6.19M
2023	166,671	$6.93M
2024incomplete	183,504	$8.05M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	33%	28,758	25,667	$12.25M
G0378	Hospital observation service, per hour	16%	4,941	2,764	$5.88M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	8.4%	4,130	3,954	$3.12M
74177	Computed tomography, abdomen and pelvis; with contrast material	4.2%	4,811	4,680	$1.54M
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	2.1%	687	686	$777K
78815	Positron emission tomography (PET) for limited area imaging	1.7%	504	500	$640K
99282	Emergency department visit for the evaluation and management, low to moderate severity	1.7%	2,831	2,749	$614K
71045	Radiologic examination, chest; single view	1.5%	9,845	9,169	$549K
70450	Computed tomography, head or brain; without contrast material	1.4%	5,114	4,945	$520K
74176	Computed tomography, abdomen and pelvis; without contrast material	1.3%	2,652	2,564	$471K
71046	Radiologic examination, chest; 2 views	1.1%	7,374	7,135	$418K
0450	Emergency room services	1.1%	9,391	8,545	$400K

259 more codes

99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	227	$342K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	875	$328K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	8,138	$288K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	1,156	$247K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	2,957	$246K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	2,955	$245K
76830	Ultrasound, transvaginal	<1%	2,904	$238K
86900		<1%	3,663	$232K
77080		<1%	1,987	$205K
72100		<1%	2,290	$203K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	1,531	$199K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	46,224	$188K
93971		<1%	748	$186K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	890	$185K
93017		<1%	457	$183K
86885		<1%	2,169	$171K
73630		<1%	2,954	$170K
73562		<1%	2,774	$163K
80051		<1%	44,145	$162K
82565		<1%	51,035	$160K
73030		<1%	2,403	$145K
0001A		<1%	3,088	$124K
73610		<1%	2,209	$122K
93970		<1%	238	$112K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	4,727	$112K
73130		<1%	1,908	$112K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	1,234	$112K
71275	Computed tomographic angiography, chest, with contrast material	<1%	493	$112K
84460		<1%	30,670	$106K
83880		<1%	6,582	$104K
76770		<1%	1,087	$101K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	533	$101K
0637		<1%	49,613	$96K
84443	Thyroid stimulating hormone (TSH)	<1%	8,425	$96K
0002A		<1%	2,404	$96K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	915	$90K
71250		<1%	676	$85K
76536		<1%	901	$85K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	3,245	$83K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	3,237	$83K
A9585	Injection, gadobutrol, 0.1 ml	<1%	1,001	$83K
82247		<1%	25,517	$80K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	388	$77K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	219	$76K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	6,599	$75K
84075		<1%	23,386	$75K
86901		<1%	3,666	$71K
84702		<1%	6,275	$69K
84450		<1%	22,381	$69K
83036	Hemoglobin; glycosylated (A1C)	<1%	9,771	$69K
72141		<1%	310	$68K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	1,855	$68K
87505		<1%	630	$67K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	465	$64K
83970		<1%	1,527	$63K
84520		<1%	36,273	$63K
80061	Lipid panel	<1%	6,724	$61K
74183		<1%	147	$60K
73110		<1%	1,082	$60K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	286	$60K
73502		<1%	827	$57K
74018		<1%	991	$56K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	2,149	$56K
86141		<1%	5,214	$51K
85027		<1%	13,289	$50K
82947		<1%	30,847	$49K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	5,232	$48K
85610		<1%	17,119	$44K
82310		<1%	11,679	$44K
73140		<1%	839	$44K
83690		<1%	14,839	$44K
81003		<1%	27,587	$43K
70496		<1%	151	$38K
83735		<1%	9,902	$38K
84484		<1%	12,191	$36K
96375	Therapeutic injection; each additional sequential IV push	<1%	4,448	$36K
82728		<1%	3,269	$35K
70486		<1%	286	$35K
99199	Unlisted special service, procedure or report	<1%	729	$34K
72125	Computed tomography, cervical spine; without contrast material	<1%	261	$32K
J3490	Unclassified drugs	<1%	2,876	$31K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	1,766	$29K
70498		<1%	119	$29K
72040		<1%	393	$26K
76641		<1%	240	$26K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	3,305	$24K
86780		<1%	2,262	$24K
82570		<1%	4,044	$23K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	587	$23K
87088		<1%	8,326	$23K
83550		<1%	3,277	$22K
82607		<1%	2,027	$22K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	370	$21K
J7030	Infusion, normal saline solution , 1000 cc	<1%	12,566	$20K
82040		<1%	5,757	$20K
84100		<1%	7,808	$20K
71101		<1%	190	$19K
73564		<1%	188	$18K
84439		<1%	2,485	$17K
80076		<1%	2,336	$17K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	1,806	$16K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	1,071	$16K
83540		<1%	3,282	$16K
82043		<1%	2,718	$15K
87340		<1%	1,872	$14K
83615		<1%	2,775	$14K
82378		<1%	668	$14K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	287	$14K
84156		<1%	3,594	$14K
87449		<1%	1,072	$14K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	1,047	$13K
86803		<1%	1,192	$13K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	946	$12K
83605		<1%	3,582	$12K
87040		<1%	5,074	$12K
86762		<1%	1,011	$12K
90686		<1%	1,299	$11K
82248		<1%	4,512	$11K
0031A		<1%	277	$11K
86787		<1%	1,041	$10K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	440	$10K
84132		<1%	2,217	$10K
97161		<1%	491	$10K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	6,746	$10K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	244	$9K
0250		<1%	7,289	$9K
85652		<1%	5,099	$9K
83520		<1%	645	$9K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	358	$8K
85730		<1%	1,832	$8K
84295		<1%	1,694	$8K
73080		<1%	123	$8K
82950		<1%	2,044	$8K
85379		<1%	1,747	$8K
82746		<1%	828	$8K
73221		<1%	31	$8K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	4,261	$7K
76870		<1%	66	$6K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	3,706	$6K
96361	Intravenous infusion, hydration; each additional hour	<1%	918	$6K
72131		<1%	46	$6K
87324		<1%	622	$6K
82077		<1%	1,209	$6K
84403		<1%	267	$6K
87210		<1%	1,625	$6K
84165		<1%	516	$5K
76380		<1%	65	$5K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	2,695	$5K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	1,110	$5K
82550		<1%	1,668	$5K
86765		<1%	408	$5K
81015		<1%	1,333	$5K
72197		<1%	12	$5K
A9609	Fludeoxyglucose f18 up to 15 millicuries	<1%	64	$4K
84153		<1%	471	$4K
86300		<1%	195	$4K
84550		<1%	1,341	$4K
77066	Tomosynthesis, mammo	<1%	28	$4K
0255		<1%	484	$4K
G0008	Administration of influenza virus vaccine	<1%	885	$4K
73590		<1%	52	$4K
87205		<1%	1,271	$3K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	234	$3K
73660		<1%	43	$3K
82962		<1%	1,162	$3K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	42	$3K
80179		<1%	675	$3K
70491		<1%	14	$3K
76881		<1%	29	$3K
82784		<1%	307	$3K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	2,293	$2K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	1,263	$2K
72050		<1%	25	$2K
87631		<1%	40	$2K
83993		<1%	112	$2K
81513		<1%	36	$2K
87081		<1%	1,070	$2K
80306		<1%	337	$2K
Z7502		<1%	112	$2K
86364		<1%	170	$2K
83721		<1%	469	$2K
86038		<1%	229	$2K
J1170	Injection, hydromorphone, up to 4 mg	<1%	1,208	$2K
86704		<1%	141	$2K
0258		<1%	1,213	$2K
J2060	Injection, lorazepam, 2 mg	<1%	1,044	$2K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	425	$1K
J1815	Injection, insulin, per 5 units	<1%	1,185	$1K
83021		<1%	189	$1K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	671	$1K
77072		<1%	12	$1K
86225		<1%	95	$1K
84145		<1%	166	$1K
72070		<1%	12	$1K
87481		<1%	52	$1K
72170		<1%	12	$1K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	12	$1K
87186		<1%	359	$1K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	517	$1K
90662		<1%	128	$991.48
90656		<1%	123	$981.44
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	36	$969.00
73100		<1%	13	$946.00
84155		<1%	315	$928.38
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	1,003	$914.20
83718		<1%	398	$800.03
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	24	$761.47
86480		<1%	37	$699.00
83001		<1%	64	$671.00
82105		<1%	42	$626.00
86308		<1%	142	$585.84
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	226	$522.67
82465		<1%	432	$504.26
82670		<1%	12	$499.50
86317		<1%	36	$489.38
84134		<1%	81	$436.26
97116		<1%	16	$366.90
80197		<1%	30	$341.00
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	61	$308.75
83930		<1%	67	$296.30
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	147	$295.31
0710		<1%	383	$270.59
82272		<1%	78	$251.00
J1644	Injection, heparin sodium, per 1000 units	<1%	314	$250.24
86140		<1%	1,321	$246.42
82150		<1%	39	$226.00
85014		<1%	560	$220.28
86677		<1%	123	$199.42
J0690	Injection, cefazolin sodium, 500 mg	<1%	217	$198.76
83935		<1%	48	$187.80
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	12	$153.00
87807		<1%	44	$138.70
82951		<1%	12	$132.00
J1650	Injection, enoxaparin sodium, 10 mg	<1%	110	$120.89
85018		<1%	78	$109.96
J1171	Injection, hydromorphone, 0.1 mg	<1%	47	$101.90
J2470	Injection, pantoprazole sodium, 40 mg	<1%	37	$86.66
0370		<1%	378	$79.59
87070		<1%	15	$67.00
J1940	Injection, furosemide, up to 20 mg	<1%	171	$63.44
82952		<1%	12	$48.00
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	48	$44.84
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	56	$42.40
86003		<1%	33	$39.00
C9113	Injection, pantoprazole sodium, per vial	<1%	15	$31.18
83655		<1%	401	$14.00
84480		<1%	31	$12.59
86431		<1%	41	$9.00
87045		<1%	14	$6.66
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	79	$3.97
J3480	Injection, potassium chloride, per 2 meq	<1%	19	$3.85
3044F		0%	551	$0.00
86160		0%	14	$0.00
80320		0%	39	$0.00
J1836	Injection, metronidazole, 10 mg	0%	23	$0.00
80329		0%	25	$0.00
85046		0%	77	$0.00
A9577	Injection, gadobenate dimeglumine (multihance), per ml	0%	16	$0.00
84146		0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSANWARI, MURTAZA (SR. VICE PRESIDENT/AREA MANAGER)